AbbVie and Myovant drugs both to face insurance scrutiny

Media coverage

• Title	AbbVie and Myovant drugs both to face insurance scrutiny
  Media name/outlet	Pharmaceutical Technology
  Country/Territory	United States
  Date	6/08/19
  URL	https://www.pharmaceutical-technology.com/comment/abbvie-insurance-scrutiny/
  Persons	Charles Ascher-Walsh

• Title	AbbVie and Myovant drugs both to face insurance scrutiny
  Media name/outlet	MarketLine NewsWire (Formerly Datamonitor)
  Country/Territory	United Kingdom
  Date	6/08/19
  Persons	Charles Ascher-Walsh